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Herein we present the data necessary for generation of alternative
means to produce equimolar mixtures of peptides (“Design and
Expression of a QconCAT Protein to Validate Hi3 Protein Quanti-
ﬁcation of Inﬂuenza Vaccine Antigens” (D.G.S. Smith, G. Gingras, Y.
Aubin, T.D. Cyr, 2016) [1]), such as QConCAT (“Trends in QconCATs
for targeted proteomics” (J. Chen, I.V. Turko, 2014) [2] , “Natural
ﬂanking sequences for peptides included in a quantiﬁcation con-
catamer internal standard” (C.S. Cheung, K.W. Anderson, M. Wang,
I.V. Turko, 2015) [3]) and SpikeTides versus the label free Hi3
approach. The experimental design and the interpretation of
results are discussed in the original article [1].
& 2016 Published by Elsevier Inc. This is an open access article
under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Chemistry
ore speciﬁc
subject areaAbsolute quantitative proteome analysisype of data Gene sequences, tables, graphs, links, fasta protein database
ow data was








D.G.S. Smith et al. / Data in Brief 9 (2016) 169–176170ata format Analyzed
xperimental
factorsThe samples were digested with a higher than usual ratios of trypsin/substrate,
source voltages optimized to reduce in-source fragmentationxperimental
featuresThe peptides were analyzed on a using a reversed phase ( BEH130 C18) column
with data independent MSMS then data analysis using PLGS 3.0 Waters Ltd.)ata source
locationn/aata accessibility Data is within this articleValue of the data
 Excellent reproducibility of peptide concentration data produced by the analysis of tryptic diges-
tions is the necessary for method comparisons. The costs associated with a particular approach in
terms of reagents and time may be a pivotal factor.
 The Hi3 method is a very valuable approach in cases of relatively simple proteomes. The speed of
method development for core laboratories can be critical. The Hi3 method is relatively straight-
forward, once reproducible results are obtained.
 The QConCAT design is very elegant but there are critical issues, such as the protein construct
solubility and stability, which require careful attention to obtain optimal results. The database
attached is necessary for analysis of the mass spectral results.1. Data
The data are compiled in the bar graphs for the quantitative proteome analyses of trivalent
inﬂuenza vaccines and standards using three methods: Hi3, QconCAT and synthetic peptides.
Databases contained either the customized QconCAT protein sequence or the full sequences of the
proteins represented therein, along with trypsin, several human keratins (cRAP from http://www.
thegpm.org/crap/) and, since the viruses are grown in chicken eggs, the entire chicken (Gallus gallus)
proteome (ftp://ftp.ensembl.org/pub/current_fasta/gallus_gallus/pep/) as well as selected full length
inﬂuenza proteins (mostly from GISAID http://platform.gisaid.org/epi3/frontend#4f5b25, and the
World Health Organization http://www.who.int/inﬂuenza/vaccines/virus/en/.2. Experimental design, materials and methods
Data was obtained by the comparison of mass spectral signal from the three most intense fully
tryptic peptides identiﬁed from the samples versus the internal standard protein. Experiments were
designed to compare the mass spectral signal strengths from equimolar tryptic peptides identiﬁed by
the Hi3 method by ﬁve different QconCAT designs as well as from synthetic peptides. The samples
analyzed were commercial trivalent inﬂuenza vaccines as well as monovalent inﬂuenza reference
standards. The mass spectra were obtained by reversed phase separation using a C18 UPLC column,
Waters nanoAcquity UPLC, directly coupled to a Waters Synapt HDMS mass spectrometer. The mass
spectrometer was programmed to carry out data-independent MSMS and incorporated a lock spray of
glu-ﬁbrinopeptide. The data was processed using Protein Lynx Global Server 3.0 for the identiﬁcation
of the three most intense peptides from a given protein identiﬁed in a custom database which has
been attached. The intensities from all charge states of a peptide are included in the software cal-
culations; however, the intensities resulting from in-source fragmentation and modiﬁed peptides
must be added manually.


















































































































OProtein Peptides (*sequence omitted in QconCAT
2)SA – Bovine Serum Albumin LVNELTEFAK
LGEYGFQNALIVR
HLVDEPQNLIK




ANELLINVK*1 – Hemagglutinin (H1N1) STQNAIDEITNK
MNYYWTLVEPGDK
EQLSSVSSFER
MNTQFTAVGK*1 – Neuraminidase A/California (H1N1) TFFLTQGALLNDK
YNGIITDTIK
YGNGVWIGR
GDVFVIR*3 – Hemagglutinin A/Victoria (H3N2) STQAAIDQINGK
IDLWSYNAELLVALENQHTIDLTDSEMNK
EFSEVEGR
WDLFVER*2 – Neuraminidase A/Victoria (H3N2) TLLMNELGVPFHLGTK
LVDSVVSWSK
VIEGWSNPK
ILFIEEGK*B – Hemagglutinin B/Brisbane LSGAMDELHNEILELDEK
LSTHNVINAENAPGGPYK
IVVDYMVQK
NLNSLSELEVK*B – Neuraminidase B/Brisbane GVTLLLPEPEWTYPR
LNVETDTAEIR
YGEAYTDTYHSYANK
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FASTA Protein Database used: 2015_2016_FluQuant.fasta
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